These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 11478803

  • 1. The HGF/SF-induced phosphorylation of paxillin, matrix adhesion, and invasion of prostate cancer cells were suppressed by NK4, an HGF/SF variant.
    Parr C, Davies G, Nakamura T, Matsumoto K, Mason MD, Jiang WG.
    Biochem Biophys Res Commun; 2001 Aug 03; 285(5):1330-7. PubMed ID: 11478803
    [Abstract] [Full Text] [Related]

  • 2. The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesis in vivo.
    Davies G, Mason MD, Martin TA, Parr C, Watkins G, Lane J, Matsumoto K, Nakamura T, Jiang WG.
    Int J Cancer; 2003 Sep 01; 106(3):348-54. PubMed ID: 12845672
    [Abstract] [Full Text] [Related]

  • 3. Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion.
    Davies G, Jiang WG, Mason MD.
    Clin Cancer Res; 2001 Oct 01; 7(10):3289-97. PubMed ID: 11595727
    [Abstract] [Full Text] [Related]

  • 4. Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist.
    Martin TA, Parr C, Davies G, Watkins G, Lane J, Matsumoto K, Nakamura T, Mansel RE, Jiang WG.
    Carcinogenesis; 2003 Aug 01; 24(8):1317-23. PubMed ID: 12807719
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of intracerebral glioblastoma growth by local treatment with the scatter factor/hepatocyte growth factor-antagonist NK4.
    Brockmann MA, Papadimitriou A, Brandt M, Fillbrandt R, Westphal M, Lamszus K.
    Clin Cancer Res; 2003 Oct 01; 9(12):4578-85. PubMed ID: 14555533
    [Abstract] [Full Text] [Related]

  • 6. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells.
    Jiang WG, Hiscox SE, Parr C, Martin TA, Matsumoto K, Nakamura T, Mansel RE.
    Clin Cancer Res; 1999 Nov 01; 5(11):3695-703. PubMed ID: 10589789
    [Abstract] [Full Text] [Related]

  • 7. NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells.
    Maehara N, Matsumoto K, Kuba K, Mizumoto K, Tanaka M, Nakamura T.
    Br J Cancer; 2001 Mar 23; 84(6):864-73. PubMed ID: 11259105
    [Abstract] [Full Text] [Related]

  • 8. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K, Matsumoto K, Date K, Shimura H, Tanaka M, Nakamura T.
    Cancer Res; 2000 Dec 01; 60(23):6737-43. PubMed ID: 11118060
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor.
    Date K, Matsumoto K, Kuba K, Shimura H, Tanaka M, Nakamura T.
    Oncogene; 1998 Dec 10; 17(23):3045-54. PubMed ID: 9881707
    [Abstract] [Full Text] [Related]

  • 10. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M, Morishita R, Nakagami H, Kuba K, Matsumoto K, Nakamura T, Tano Y, Kaneda Y.
    Diabetologia; 2003 Jan 10; 46(1):115-23. PubMed ID: 12637990
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model.
    Tomioka D, Maehara N, Kuba K, Mizumoto K, Tanaka M, Matsumoto K, Nakamura T.
    Cancer Res; 2001 Oct 15; 61(20):7518-24. PubMed ID: 11606388
    [Abstract] [Full Text] [Related]

  • 12. Epithelial cell spreading induced by hepatocyte growth factor influences paxillin protein synthesis and posttranslational modification.
    Hopkins AM, Bruewer M, Brown GT, Pineda AA, Ha JJ, Winfree LM, Walsh SV, Babbin BA, Nusrat A.
    Am J Physiol Gastrointest Liver Physiol; 2004 Oct 15; 287(4):G886-98. PubMed ID: 15191880
    [Abstract] [Full Text] [Related]

  • 13. Nk4, a new HGF/SF variant, is an antagonist to the influence of HGF/SF on the motility and invasion of colon cancer cells.
    Parr C, Hiscox S, Nakamura T, Matsumoto K, Jiang WG.
    Int J Cancer; 2000 Feb 15; 85(4):563-70. PubMed ID: 10699931
    [Abstract] [Full Text] [Related]

  • 14. Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases.
    Harvey P, Clark IM, Jaurand MC, Warn RM, Edwards DR.
    Br J Cancer; 2000 Nov 15; 83(9):1147-53. PubMed ID: 11027427
    [Abstract] [Full Text] [Related]

  • 15. Hepatocyte growth factor/scatter factor is implicated in the mode of stromal invasion of uterine squamous cervical cancer.
    Shimabukuro K, Ichinose S, Koike R, Kubota T, Yamaguchi M, Miyasaka M, Aso T.
    Gynecol Oncol; 2001 Nov 15; 83(2):205-15. PubMed ID: 11606073
    [Abstract] [Full Text] [Related]

  • 16. Complex formation of IQGAP1 with E-cadherin/catenin during cohort migration of carcinoma cells. Its possible association with localized release from cell-cell adhesion.
    Shimao Y, Nabeshima K, Inoue T, Koono M.
    Virchows Arch; 2002 Aug 15; 441(2):124-32. PubMed ID: 12189501
    [Abstract] [Full Text] [Related]

  • 17. Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4.
    Heideman DA, van Beusechem VW, Bloemena E, Snijders PJ, Craanen ME, Offerhaus GJ, Derksen PW, de Bruin M, Witlox MA, Molenaar B, Meijer CJ, Gerritsen WR.
    J Gene Med; 2004 Mar 15; 6(3):317-27. PubMed ID: 15026993
    [Abstract] [Full Text] [Related]

  • 18. Effect of hepatocyte growth factor on invasion of prostate cancer cell lines.
    Fujiuchi Y, Nagakawa O, Murakami K, Fuse H, Saiki I.
    Oncol Rep; 2003 Mar 15; 10(4):1001-6. PubMed ID: 12792760
    [Abstract] [Full Text] [Related]

  • 19. Targeting the HGF/SF receptor c-met using a hammerhead ribozyme transgene reduces in vitro invasion and migration in prostate cancer cells.
    Davies G, Watkins G, Mason MD, Jiang WG.
    Prostate; 2004 Sep 01; 60(4):317-24. PubMed ID: 15264243
    [Abstract] [Full Text] [Related]

  • 20. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ, Chen WK, Wang CJ, Lin WL, Tseng TH.
    Toxicol Appl Pharmacol; 2008 Jan 15; 226(2):178-91. PubMed ID: 17961621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.